Probiotic Chocolate for Multiple Sclerosis
(ProChocolate Trial)
Trial Summary
What is the purpose of this trial?
The goal of this study is to assess the effects of probiotics on persons with multiple sclerosis (MS), persons at higher genetic risk for MS (first degree family members of persons with MS), and healthy controls. Participants will be asked to consume probiotic containing chocolates (Bouchard Belgian Dark Chocolate Probiotic Napolitains containing 10 billion CFUs of bifidobacterium longum per day) for 6 weeks. Participants will undergo blood draws before and after the 6 weeks of probiotic containing chocolate and microbial metabolites and immune markers will be compared before and after the probiotics, as well as between groups.
Research Team
Rebecca Straus Farber, MD
Principal Investigator
Columbia University
Eligibility Criteria
This trial is for people with multiple sclerosis, their first-degree relatives at higher genetic risk for MS, and healthy individuals. Participants will eat probiotic chocolate daily for 6 weeks and have blood tests before and after to check immune markers.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Ramp-up
Participants consume 2 probiotic chocolates per day to acclimate to the dosage
Treatment
Participants consume 5 probiotic chocolates per day for 6 weeks
Follow-up
Participants are monitored for changes in immune markers and microbial metabolites
Treatment Details
Interventions
- Bouchard Belgian Dark Chocolate Probiotic Napolitains
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor